CINECA IRIS Institutional Research Information System

ROETTO, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.375
AS - Asia 4.546
EU - Europa 3.370
SA - Sud America 451
AF - Africa 88
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 4
Totale 15.862
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.216
SG - Singapore 1.779
CN - Cina 1.421
IT - Italia 592
VN - Vietnam 467
FR - Francia 419
IE - Irlanda 418
BR - Brasile 365
SE - Svezia 350
FI - Finlandia 335
DE - Germania 265
DK - Danimarca 241
UA - Ucraina 227
KR - Corea 220
JP - Giappone 137
IN - India 134
HK - Hong Kong 114
GB - Regno Unito 105
CA - Canada 90
PL - Polonia 85
AT - Austria 72
NL - Olanda 54
BE - Belgio 52
MX - Messico 50
ID - Indonesia 43
AR - Argentina 40
BD - Bangladesh 33
TW - Taiwan 32
ES - Italia 29
AU - Australia 25
IQ - Iraq 22
PT - Portogallo 20
TR - Turchia 20
RU - Federazione Russa 19
CZ - Repubblica Ceca 16
ZA - Sudafrica 16
PK - Pakistan 14
RO - Romania 14
CH - Svizzera 13
EG - Egitto 13
ET - Etiopia 13
EC - Ecuador 12
PH - Filippine 10
TH - Thailandia 10
VE - Venezuela 10
IL - Israele 9
GR - Grecia 8
JO - Giordania 8
KE - Kenya 8
LT - Lituania 8
MY - Malesia 8
SA - Arabia Saudita 8
CL - Cile 7
DZ - Algeria 7
UZ - Uzbekistan 7
AL - Albania 6
HR - Croazia 6
OM - Oman 6
SN - Senegal 6
AZ - Azerbaigian 5
CO - Colombia 5
IR - Iran 5
LB - Libano 5
MA - Marocco 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
EU - Europa 4
JM - Giamaica 4
NG - Nigeria 4
PE - Perù 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
KZ - Kazakistan 3
LK - Sri Lanka 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
PS - Palestinian Territory 3
PY - Paraguay 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
BF - Burkina Faso 2
BG - Bulgaria 2
BO - Bolivia 2
BS - Bahamas 2
GA - Gabon 2
HN - Honduras 2
LV - Lettonia 2
MT - Malta 2
NZ - Nuova Zelanda 2
QA - Qatar 2
UG - Uganda 2
AF - Afghanistan, Repubblica islamica di 1
BJ - Benin 1
BZ - Belize 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
Totale 15.850
Salva come PNG Salva come JPEG
Città #
Singapore 1.005
Chandler 727
Beijing 622
Dallas 518
Ashburn 512
Ann Arbor 445
Dublin 417
San Jose 406
Fairfield 252
Houston 249
Santa Clara 249
Villeurbanne 215
Wilmington 167
The Dalles 159
Seattle 132
Princeton 129
Turin 128
Medford 127
Jacksonville 125
Los Angeles 120
Woodbridge 120
Dearborn 116
Columbus 107
Lauterbourg 107
Ho Chi Minh City 106
Torino 102
Cambridge 100
Nyköping 92
Hanoi 88
Hong Kong 82
Pisa 82
Warsaw 80
Buffalo 72
Boardman 67
Tokyo 67
Boston 64
Munich 64
Redwood City 63
Shanghai 59
Dong Ket 56
Vienna 54
Helsinki 47
New York 47
Guangzhou 41
Pune 39
Nanjing 38
Fremont 37
Council Bluffs 34
Brussels 32
Jakarta 32
Milan 29
Wuhan 29
Düsseldorf 28
Hangzhou 28
San Diego 28
Seoul 27
Hefei 26
Toronto 25
Turku 25
Washington 24
São Paulo 23
Frankfurt am Main 22
Orem 22
Changsha 21
Phoenix 21
Redondo Beach 21
Chengdu 20
Montreal 20
San Mateo 19
Atlanta 17
Da Nang 17
Mexico City 17
Nuremberg 17
Rome 17
Shenyang 17
Taipei 17
Dresden 16
Haiphong 16
London 16
Chennai 15
Norwalk 15
Paris 15
Stockholm 15
Tianjin 15
Jinan 14
Nanchang 14
Silver Spring 13
Waanrode 13
Chicago 12
Johannesburg 12
Lappeenranta 12
Zhengzhou 12
Des Moines 11
Amsterdam 10
Brno 10
Chongqing 10
Nijmegen 10
Padova 10
Baghdad 9
Falls Church 9
Totale 9.680
Salva come PNG Salva come JPEG
Nome #
Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer 823
Comparison of 3 Tfr2-deficient murine models suggestsdistinct functions for Tfr2-alpha and Tfr2-beta isoforms in different tissues 491
A comparative study of myocardial molecular phenotypes of two tfr2β null mice: Role in ischemia/reperfusion 383
Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells 366
Two novel mutations in the tmprss6 gene associated with iron-refractory iron-deficiency anaemia (irida) and partial expression in the heterozygous form 309
Hemochromatosis due to mutations in transferrin receptor 2. 278
Analysis of microsatellite instability in chronic lymphoproliferative disorders 267
Development of cellular and humoral response against WT1 protein vaccination in mice 253
A child with hyperferritinemia: case report 252
Transferrin Receptor 2 Dependent Alterations of Brain Iron Metabolism Affect Anxiety Circuits in the Mouse 248
Altered Erythropoiesis in Mouse Models of Type 3 Hemochromatosis 246
Hepatic expression of hemochromatosis genes in two mouse strains after phlebotomy and iron overload. 224
Rare Genetic Anemias Due to Defective Iron Recycling: Aceruloplasminemia and Type 4 Hemochromatosis 220
The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice 220
Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (C70R). 210
The ancestral hemochromatosis haplotype is associated with a severe phenotype expression in Italian patients 205
Allelic association of microsatellites of 6p in Italian hemochromatosis patients 204
Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signalling 196
Characterization of human mitochondrial ferritin promoter: Identification of transcription factors and evidences of epigenetic control 192
ANALYSIS OF IRON METABOLISM IN TFR2 TARGETED ANIMALS BRAIN 189
Wnt5a is a key target for the pro-osteogenic effects of iron chelation on osteoblast progenitors 189
Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism 179
TFR2 AND EpoR EXPRESSION AT DIAGNOSIS AS POSSIBLE PREDICTORS OF ERYTHROPOIETIN TREATMENT RESPONSE IN MDS PATIENTS 176
THE PHENOTYPE OF TFR2-TMPRSS6 DOUBLE KNOCK OUT MICE ONLY PARTIALLY OVERLAPS THAT OF TMPRSS6 NULL MICE 175
Post-translational down-regulation of Nrf2 and YAP proteins, by targeting deubiquitinases, reduces growth and chemoresistance in pancreatic cancer cells 165
Altered erythropoiesis in mouse models of type 3 Hemochromatosis (Hh3) 163
Iron Overload, Oxidative Stress, and Ferroptosis in the Failing Heart and Liver 161
Feasibility of molecular diagnosis of alpha-thalassemia in the evaluation of microcytosis 156
null 154
COMPORTAMENTO ANSIOSO NEI TOPI TFR2 KO: NUOVO COLLEGAMENTO TRA SOVRACCARICO CEREBRALE DI FERRO E ANSIA NELLE MALATTIE NEURODEGENERATIVE? 152
Patologie da sovraccarico di ferro 152
A pilot C282Y hemochromatosis screening in Italian newborns by TaqMan technology. 151
Deferasirox is a powerful NF-kappaB inhibitor inmyelodysplastic cells and in leukemia cell lines acting independently from celliron deprivation by chelation and reactive oxygen species scavenging 148
ALTERED MRNAS EXPRESSION OF GENES INVOLVED IN CELLULAR IRON HOMEOSTASIS IN LUNG NON SMALL CELLS CARCINOMA 147
Identification of New BMP6 Pro-Peptide Mutations in Patients with Unexplained Iron-Overload 145
The Functional Versatility of Transferrin Receptor 2 and Its Therapeutic Value 142
BBB damage in aging causes brain iron deposits via astrocyte-neuron crosstalk and Hepc/Fpn1 pathway activation 141
A recombination event close to HFE gene in hereditary hemochromatosis 140
A valine deletion of ferroportin 1: a common mutation in hemochromastosis type 4 139
Construction of a YAC contig covering human chromosome 6p22 139
Activation of the Hepcidin-Ferroportin1 pathway in the brain and astrocytic–neuronal crosstalk to counteract iron dyshomeostasis during aging 137
Anemia and iron overload due to genetic defects of iron recycling, aceruloplasminemia and hemochromatosis type 4 135
Identification of a Novel Mutation in the L Ferritin Iron-Responsive Element Causing Hereditary Hyperferritinemia-Cataract Syndrome 131
Brain iron deposits during aging: activation of the Hepc/Fpn1 pathway. 126
Anemia and iron overload due to compound heterozygosity for novel ceruloplasmin mutations. 124
New polymorphisms and markers in the HLA class I region: relevance to hereditary hemochromatosis (HFE) 124
Comprehensive analysis of mitochondrial and nuclear DNA variations in patients affected by hemoglobinopathies: A pilot study 124
Tfr2 KO mice show brain iron overload with microglia alterations and anxious behavior 120
Iron: An Essential Element of Cancer Metabolism 120
The Molecular Spectrum of β- and α-Thalassemia Mutations in Non-Endemic Umbria, Central Italy 119
Construction of a genetic map telomeric to HAL-A by microsatellite analysis 118
A Portuguese patient homozygous for the -25G>A mutation of the HAMP promoter shows evidence of steady-state transcription but fails to up-regulate hepcidin levels by iron. 118
Serum erythropoietin and circulating transferrin receptor in thalassemia intermedia patients with heterogeneous genotypes 116
Detection of a rare mutation in the ferroportin gene through targeted next generation sequencing 113
Detection of humoral immune responses against WT1 antigenin patients affected by different hematological malignancies 112
TFR2 BETA ISOFORM HAS A ROLE IN CARDIAC IRON METABOLISM 112
Identification of new BMP6 pro-peptide mutations in patients with iron overload 112
A novel mutation in the CUB sequence of matriptase-2 (TMPRSS6) is implicated in iron-resistant iron deficiency anaemia - response to Jasperset al 112
Deferasiroxtreatment improved the hemoglobin level and decreased transfusion requirements infour patients with the myelodysplastic syndrome and primary myelofibrosis 111
Tfr2 Beta null mice have an increase cardiac ischemia/reperfusion tolerance 110
Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis 109
Hereditary hemochromatosis: Generation of a transcription map within a refined and extended map of the HLA class I region 108
Two polymorphic repeats in the candidate region for the haemochromatosis gene 106
Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma 105
New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. 105
A new mutation (G51C) in the iron-responsive element (IRE) of L-ferritin associated with hyperferritinaemia-cataract syndrome decreases the binding affinity of the mutated IRE for iron-regulatory proteins. 105
Molecular and clinical studies in hemochromatosis type 2 and 3 104
Nrf2 role in the BRAFi/MEKi acquired resistance in melanoma 103
Analysis of NCOA4/Tfr2 as PB markers of iron increase during ageing 99
Linkage analysis of 6p21 polymorphic markers and the hereditary hemochromatosis: localization of the gene centromeric to HLA-F 98
Comparison of clinical expression of type 2 (juvenile) and type 3 hemochromatosis. RID B-1183-2008 98
Protocol for reticulocyte enrichment from low-volume human blood samples from alpha-thalassemic and healthy participants 96
HETEROZYGOUS β-THALASSEMIA AND HOMOZYGOUS H63D HEMOCHROMATOSIS IN A CHILD: A 16-YEAR FOLLOW-UP 96
Simultaneous screening of known HFE and TFR2 mutations in blood donors selected for increaesd serum iron parameters. 96
Comparison of clinical expression of type 2 (juvenile) and type 3 hemochromatosis. RID B-1183-2008 92
Heterogeneity of hemochromatosis in Italy 89
Juvenile hemochromatosis locus maps to chromosome 1q. 88
Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation 87
The natural history of hemochromatosis type 2. 87
Genetic haemochromatosis: genes and mutations associated with iron loading. 86
Non-HFE hemochromatosis: insights into regulation on iron metabolisms from novel iron loading disorders. 85
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. 84
New insights into iron homeostasis through the study of non-HFE hereditary haemochromatosis. 84
A frequent polymorphism in the 5' region of the BCMA gene 83
Mutations in transferrin receptor-2 in hemochromatosis type 3. 82
Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene. 82
Lack of Hfe and TfR2 in Macrophages Impairs Iron Metabolism in the Spleen and the Bone Marrow 80
Juvenile and adult hemochromatosis are distinct genetic disorders 80
Hereditary hemochromatosis: progress and perspectives 78
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. 77
Commentary: Juvenile hemochromatosis in a Spanish family (by Montes-Cano et al.). 77
Different hematological phenotypes caused by the interaction of triplicated alpha-globin genes and heterozygous beta-thalassemia 77
Molecular defects in two genetic disorders of iron recycling: aceruloplasminemia and hemochromatosis type 4 75
Fisiopatologia Molecolare del Matbolismo del ferro 75
Mutation analysis of the HLA-H gene in Italian hemochromatosis patients 75
Liver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia. 74
TFR2-Related Hereditary Hemochromatosis 74
Hereditary Hemochromatosis 73
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. 72
Recurrent mutations in the iron regulatory element of L-ferritin in hereditary hyperferritinemia-cataract syndrome. 71
Totale 14.799
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.082
article - articoli 0
book - libri 0
conference - conferenze 9.311
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.393
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021171 0 0 0 0 0 0 0 0 0 0 0 171
2021/20221.522 75 53 53 129 71 69 119 102 81 148 338 284
2022/20231.954 225 162 61 225 205 514 131 93 165 29 89 55
2023/2024858 100 170 54 70 63 129 23 45 7 45 55 97
2024/20252.364 45 120 74 261 488 133 92 135 309 154 187 366
2025/20264.645 444 161 689 495 603 305 754 167 402 410 150 65
Totale 16.339